Brief: Emcure Pharmaceuticals Says Tillomed Acquires Strategic Pharma Portfolio From Manx
04/04/2025 08:39
April 4 (Reuters) - Emcure Pharmaceuticals Ltd EMCU.NS: TILLOMED ACQUIRES STRATEGIC PHARMA PORTFOLIO FROM MANX DEAL FOR AROUND £ 19.7 MlN Source text: ID:nnAZN3NRFMY Further company coverage: EMCU.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Emcure Pharmaceuticals
See all newsIndia's Emcure Pharma rises on Poviztra approval, Motilal initiation with 'buy'
Brief: Emcure Pharmaceuticals Ltd To Expand Use Of Poviztra For Mash Indication Following CDSCO Approval
Brief: Emcure Pharmaceuticals Says Kuber Jagdale, President, API Business, Superannuates
India's Emcure Pharma hits record high after Jefferies raises TP
Brief: Emcure Pharmaceuticals March-Quarter Consol Net Profit 2.43 Billion Rupees